PYY and neoplasm: A preclinical study shows that TJ-48 inhibits the production of IL-6, MCP-1, PYY, and GLP-1 and ameliorates cancer-induced anemia using a CT-26 tumor-bearing mouse cancer anorexia/cachexia model [125].